Graph-backed node

Global RNA Therapeutics Market Size and Share Analysis 2026-2033

The global RNA therapeutics market is anticipated to experience rapid and transformative expansion during the forecast period from 2026 to 2033. Valued at approximately USD 6.9 billion in 2025, the market is projected to reach nearly USD 22.4 billion by 2033, registering a CAGR of around 15.8%. Market growth is being fueled by significant advancements in genetic and molecular medicine, increasing prevalence of chronic and rare diseases, rising adoption of precision and personalized therapies, and continuous innovation in RNA delivery platforms and therapeutic development technologies.

market_report MIMR-node_9b8b8ca

Global RNA Therapeutics Market Size and Share Analysis 2026-2033

About this node

Hierarchy

Parent node Pheonix Research MIWS-root Parent node Pharmaceuticals MIIN-node_fb40ad7 Parent node Pharmaceuticals MISG-node_4662f20

Mentioned companies

Company Moderna Inc organization Company BioNTech SE organization

Dataset

Value

Base: 6.9
Cagr: 15.8
Currency: USD
Forecast: 22.4
Unit: Billion

Temporal

Base Year: 2025
Forecast Year: 2033

Scope

Coverage Name: Asia Pacific, Europe, Middle East & Africa, North America, South America
Coverage Type: Global

Volume

Unit: Units

Intelligence

Competitive

Intensity Level: high
Market Structure Type: oligopolistic
Tier1 Player Count: 12

Investment

Capital Intensity Level: high
Recent Mna Activity: yes
Trend Direction: rising

Regulatory

Approval Pathway Structure: standardized_commercial
Complexity Level: high

Risk

Geopolitical Exposure Level: moderate
Overall Level: high
Substitution Risk Level: moderate

Technology

Innovation Intensity Level: high
Maturity Stage: mature
Patent Activity Level: high

Value Chain

Distribution Structure: hybrid
Primary Operational Model: hybrid
Supply Chain Complexity Level: high

FAQ

What is the current size of the global RNA therapeutics market

The global RNA therapeutics market was valued at approximately USD 6.9 billion in 2025, supported by rapid advancements in genetic medicine, mRNA technology, and increasing investment in biotechnology research.

What is the projected market size of the RNA therapeutics market by 2033?

The market is expected to reach nearly USD 22.4 billion by 2033, expanding at a strong CAGR of around 15.8% during the forecast period from 2026 to 2033.

What are the major factors driving growth in the RNA therapeutics market?

Key growth drivers include breakthroughs in mRNA technology, rising demand for precision and personalized medicine, increasing prevalence of chronic and rare diseases, advancements in RNA delivery systems, and expanding clinical pipelines for RNA-based drugs.

Who are the leading companies in the Global RNA Therapeutics Market?

Oncology is one of the leading application areas due to the strong potential of RNA-based immunotherapies, targeted cancer treatments, and ongoing clinical research in tumor biology.

Knowledge bases

Knowledge base Wikidata https://www.wikidata.org/wiki/Q1901028

Media

Role: primary_image
Width: 1407
Height: 768

Graph context

Environment: live

Freshness: 2026-06-12T19:44:36+00:00

Resolved node: MIMR-node_9b8b8ca

Discovery

Statsfocus

https://statsfocus.com

Knowledge graph of market intelligence